Member Info for daveycaferacer

Christen Ager-Hanssen, the chief executive of Custos Group, who's Johnston Press' largest shareholder says the board has been 'rearranging the deck chairs on the titanic' as Sky News reveals the owner of the Daily Mail is plotting to buy the i newspaper from the company.

https://twitter.com/srbeasley/status/1062311144826773504

FALUCA study of Fruquintinib in third line non-small cell lung cancer imminent - with NDA to surely follow shortly afterwards

I caught some of this on Twitter from Brad Loncar but he has since written a great piece on Ch-Med, which can be found on the Loncar Funds website:-

https://www.loncarfunds.com/behind_the_scenes_at_chi-med/

For anyone interested in the wider sector Brad is certainly worth a follow on Twitter

@bradloncar

agreed amones, and the few people who are active rarely post. Therefore it would be useful if more Investors used the site. The bots are a little irritating .....

Hopefully big pipeline news coming before the end of the year. I am particularly looking forward to all the updates on Savolitinib including he molecular epidemiology study in PRCC and any updates on BTD.

I see AZ had some great results this week and continue with their disposal of non core assets with the focus on Oncology & Respiratory.

Just a friendly reminder that if anyone would care to join me on a U.S. Bulletin Board, Stocktwits is free and very nice to use. It also has some subject forums, such as Biotech.

Today, I have created a new Chatroom called ChinaBiotech

https://stocktwits.com/

We currently have 294 followers on Chi-Med, which has remained consistent for the last 6 months. Most Individual Investors appear to be traders....few are interested in investing for term but there are a few posters who do get the investment case!

I continue to buy

I meant DavidGlobal on iii

SlowRoll, yes David on iii but like most, I dislike the new website so only post my thoughts on HCM on here and advfn now ;o-)

Good volume today, but like Vegemite, a nasty spread

I see the last criminal CEO of the previously named Company has used my money to setup a vineyard in Hampshire

Mark Mallon, AZ EVP for Global Product and Portfolio Strategy, Global Medical Affairs and Corporate Affairs, gave his insight on how digital health is evolving in China at #FTPharma earlier this week.

https://twitter.com/AstraZeneca/status/1059864105488539648

the heads of business development for $BGNE and $ZLAB together with Brad Loncar are participating in a free educational webinar hosted by @defined_health discussing the licensing landscape in China

https://twitter.com/bradloncar/status/1059544225686216709

thanks Slowroll, IC have been very positive for years, nice to see they are consistent and recognise the huge potential

I think you have too much time on your hands NA....filling in time between Giros?

For those of a technical bent:-

https://dividendbot.com/?s=HCM

Maybe Leon has more of an idea as to what's going on that Leo does

"Leon Coetzer" said "“definitely still going ahead”

Thanks Leon

Our CEO seems to talk in riddles and tie himself up in knots, anyone worked out the cash burn? More funding must be required fairly soon, if only to keep the lights on in the office?

we could have another placing soon although I am unsure the Co. would be successful now

"There are however certain procedural amendments required ". more brown envelopes reqd

ADR Volume has been very good for the last week, nice price increase which is a pity for me as I will be making another large purchase next month!